| |
| |
|
| Insider
Information: |
Schranz Jennifer |
| Relationship: |
Chief Medical Officer |
| City: |
King Of Prussia |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
39,125 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$15,407 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
39,125 |
|
|
| Total
Value |
$15,407 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nabriva Therapeutics AG |
NBRV |
Chief Medical Officer |
2021-02-28 |
39,125 |
2018-06-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2021-02-28 |
4 |
D |
$2.39 |
$79 |
D/D |
(33) |
39,125 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2021-01-31 |
4 |
D |
$2.62 |
$94 |
D/D |
(36) |
39,158 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
39,194 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2020-12-31 |
4 |
D |
$2.42 |
$73 |
D/D |
(30) |
16,694 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2020-11-30 |
4 |
D |
$0.43 |
$129 |
D/D |
(301) |
167,240 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2020-10-31 |
4 |
D |
$0.50 |
$149 |
D/D |
(301) |
167,541 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2020-09-30 |
4 |
D |
$0.53 |
$160 |
D/D |
(301) |
167,842 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2020-08-31 |
4 |
D |
$0.62 |
$186 |
D/D |
(301) |
168,143 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2020-07-31 |
4 |
D |
$0.76 |
$229 |
D/D |
(301) |
168,444 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2020-06-30 |
4 |
D |
$0.67 |
$203 |
D/D |
(301) |
168,745 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2020-05-31 |
4 |
D |
$1.14 |
$343 |
D/D |
(301) |
169,046 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2020-04-30 |
4 |
D |
$0.55 |
$165 |
D/D |
(301) |
169,347 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2020-03-31 |
4 |
D |
$0.58 |
$173 |
D/D |
(301) |
169,648 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2020-02-28 |
4 |
D |
$1.35 |
$406 |
D/D |
(301) |
169,949 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2020-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
105,000 |
158,705 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2020-01-31 |
4 |
D |
$1.35 |
$5,798 |
D/D |
(4,295) |
53,705 |
0 |
- |
|
| NBRV |
Nabriva Therapeutics AG |
Chief Medical Officer |
• – – |
2018-06-22 |
4 |
B |
$3.73 |
$20,515 |
D/D |
5,500 |
5,500 |
2.74 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
